[go: up one dir, main page]

DE68904264D1 - Fragmente und fraktionen von heparin mit wirkung gegen hiv. - Google Patents

Fragmente und fraktionen von heparin mit wirkung gegen hiv.

Info

Publication number
DE68904264D1
DE68904264D1 DE8989202061T DE68904264T DE68904264D1 DE 68904264 D1 DE68904264 D1 DE 68904264D1 DE 8989202061 T DE8989202061 T DE 8989202061T DE 68904264 T DE68904264 T DE 68904264T DE 68904264 D1 DE68904264 D1 DE 68904264D1
Authority
DE
Germany
Prior art keywords
fractions
heparin
fragments
effect against
against hiv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8989202061T
Other languages
English (en)
Other versions
DE68904264T2 (de
Inventor
Henricus Carl Josep Ottenheijm
Hollander Franciscus Corne Den
Clercq Erik Desire Alice De
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Akzo NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo NV filed Critical Akzo NV
Publication of DE68904264D1 publication Critical patent/DE68904264D1/de
Application granted granted Critical
Publication of DE68904264T2 publication Critical patent/DE68904264T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C08B37/0078—Degradation products

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicinal Preparation (AREA)
DE8989202061T 1988-08-24 1989-08-09 Fragmente und fraktionen von heparin mit wirkung gegen hiv. Expired - Fee Related DE68904264T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8802087 1988-08-24

Publications (2)

Publication Number Publication Date
DE68904264D1 true DE68904264D1 (de) 1993-02-18
DE68904264T2 DE68904264T2 (de) 1993-05-27

Family

ID=19852794

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8989202061T Expired - Fee Related DE68904264T2 (de) 1988-08-24 1989-08-09 Fragmente und fraktionen von heparin mit wirkung gegen hiv.

Country Status (13)

Country Link
EP (1) EP0355905B1 (de)
JP (1) JPH02108624A (de)
KR (1) KR0143084B1 (de)
AT (1) ATE84217T1 (de)
AU (1) AU617850B2 (de)
CA (1) CA1330305C (de)
DE (1) DE68904264T2 (de)
DK (1) DK416089A (de)
ES (1) ES2053953T3 (de)
IE (1) IE61565B1 (de)
NZ (1) NZ230394A (de)
PT (1) PT91524B (de)
ZA (1) ZA896231B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08109134A (ja) * 1994-10-11 1996-04-30 Sanwa Kagaku Kenkyusho Co Ltd 細胞変成抑制並びに臓器毒性軽減剤
US6001820A (en) * 1995-03-31 1999-12-14 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
DE69623840D1 (de) * 1995-03-31 2002-10-31 Hamilton Civic Hospitals Res Zusammensetzung zur Hemmung der Thromboseentstehung
US5744457A (en) * 1995-03-31 1998-04-28 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
US5763427A (en) * 1995-03-31 1998-06-09 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
US5767269A (en) * 1996-10-01 1998-06-16 Hamilton Civic Hospitals Research Development Inc. Processes for the preparation of low-affinity, low molecular weight heparins useful as antithrombotics
DE19836339B4 (de) 1998-08-11 2011-12-22 N.V. Nutricia Kohlenhydratmischung
ATE358486T1 (de) * 2000-11-09 2007-04-15 Contrimmune Biotechnology Inc Verwendung von xestospongin c zur behandlung oder vorbeugung einer hiv-infektion
FR2838649B1 (fr) * 2002-04-19 2006-01-13 Commissariat Energie Atomique Composition anti-vih, procede de fabrication et medicament
US20040229778A1 (en) * 2003-05-13 2004-11-18 Elmaleh David R. Pharmaceutical compositions of antithrombin III for the treatment of retroviral diseases
EP1597978A1 (de) 2004-05-17 2005-11-23 Nutricia N.V. Synergie von GOS und polyfruktose
US8252769B2 (en) 2004-06-22 2012-08-28 N. V. Nutricia Intestinal barrier integrity
EP1721611A1 (de) * 2005-04-21 2006-11-15 N.V. Nutricia Nahrungsergänzungspräparat mit Oligosacchariden für eine Kategorie von HIV Patienten
JP5377643B2 (ja) 2009-07-03 2013-12-25 テイ・エス テック株式会社 乗物用シート
JP5757639B2 (ja) 2010-09-14 2015-07-29 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ セルピンフィンガー融合ポリペプチド

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3422518A1 (de) * 1984-06-16 1985-12-19 B. Braun Melsungen Ag, 3508 Melsungen Heparin-derivate, verfahren zu ihrer herstellung, diese enthaltende arzneimittel und ihre verwendung bei der behandlung von fettstoffwechselstoerungen
NZ222695A (en) * 1986-11-29 1990-03-27 Ueno Seiyaku Oyo Kenkyujo Kk Synergistic antiviral compositions
WO1990003791A1 (en) * 1988-10-05 1990-04-19 Nicola Diferrante Methods for interfering with hiv multiplication and composition for the treatment of aids

Also Published As

Publication number Publication date
CA1330305C (en) 1994-06-21
IE892565L (en) 1990-02-24
ES2053953T3 (es) 1994-08-01
NZ230394A (en) 1997-02-24
IE61565B1 (en) 1994-11-16
AU617850B2 (en) 1991-12-05
ATE84217T1 (de) 1993-01-15
ZA896231B (en) 1990-05-30
EP0355905A1 (de) 1990-02-28
PT91524B (pt) 1995-07-18
EP0355905B1 (de) 1993-01-07
DK416089D0 (da) 1989-08-23
KR900002788A (ko) 1990-03-23
KR0143084B1 (ko) 1998-07-15
DE68904264T2 (de) 1993-05-27
PT91524A (pt) 1990-03-08
JPH02108624A (ja) 1990-04-20
AU4001289A (en) 1990-03-01
DK416089A (da) 1990-02-25

Similar Documents

Publication Publication Date Title
DE68904264D1 (de) Fragmente und fraktionen von heparin mit wirkung gegen hiv.
ATE264914T1 (de) Antivirale proteine, dafür kodierende dna, und deren verwendung
FI952302L (fi) Pyran-2-onit ja 5,6-dihydropyranonit, jotka ovat käyttökelpoisia HIV:n ja muiden retrovirusten hoidossa
PT94247A (pt) Processo para a preparacao de uma composicao farmaceutica contendo 3'-azido-3'-desoxitimidina e n-butil-desoxinojirimicina e metodo para inibir hiv utilizando-a
DE69233760D1 (de) Inhibitoren der menschlichen Elastase von Neutrophilen
PT88930A (pt) Processo para a preparacao de novos analogos de nucleosidos e de composicoes farmaceuticas que os contem
FI911574A7 (fi) Uusia HIV-proteiineja ja -peptidejä, jotka ovat käyttökelpoisia aidsin toteamisessa, ennaltaehkäisyssä ja hoidossa
ES2130114T3 (es) 5,11-dihidro-6h-dipirido(3,2-b:2',3'-e)(1,4)diazepinas y su uso en la prevencion o tratamiento de infeccion por hiv.
SE9602931L (sv) Ny medicinsk användning
EE9400183A (et) Inimese immuunpuudulikkuse viiruse vaktsiin ja kasutamine
GR1000419B (el) Μορφη δοσολογιας για χορηγηση ανταγωνιστη του ασβεστιου.
FI962685A7 (fi) 2,3-diaryyli-1-bentsopyraanijohdannaisten käyttö lääkkeen valmistamise ksi luukadon ja osteoporoosin hoitamiseksi ja estämiseksi
ATE81980T1 (de) Pharmazeutisches kombinationspraeparat sowie dessen herstellung und verwendung.
DE69023708D1 (de) Anti-hiv-heilmittel.
IT8823121A0 (it) Derivati della 1,2,5,6-tetraidropiridina, loro procedimento di preparazione e loro impiego come sostanze medicinali
DE68914990D1 (de) Verfahren zur inhibierung der wirkung des menschlichen immunschwäche-virus (hiv) in vivo.
EP0681578A1 (de) Gegen virussen wirksam naphtochinon verbindungen, zusammensetzungen und deren verwendungen.
ATE58478T1 (de) Zubereitungen und verfahren zum schutz von tlymphozyten gegen das krankheitsagens von lymphadenopathie und vom erworbenen immundepressionsyndrom.
EP0325768A3 (en) Non-reverting rna viruses
ES2108680T3 (es) Uso del derivado n-n-butilo de desoxinojirimicina en la fabricacion de un medicamento.
EP0311107A3 (de) Anti-HIV-aktive 3'-Fluoro-purin-2',3'-dideoxyriboside
AU2880595A (en) Use of pharmaceutical agents for restoring, alleviation, or treatment of immunodeficiency, including the alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses
KR950702838A (ko) 인터루킨-4(IL-4)를 사용한 사람 면역결핍 바이러스(HIV) 복제의 억제방법(Method for inhibiting HIV replication using IL-4)
WO1990005523A3 (en) Phenanthrolinedicarboxylate esters, 4-aminoquinoline and isoquinoline derivatives as inhibitors of hiv reverse transcriptase
ATE64855T1 (de) Zubereitungen und verfahren zum schutz von tlymphozyten gegen das krankheitsagens von lymphadenopathie und vom erworbenen immundepressionsyndrom.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: AKZO NOBEL N.V., ARNHEIM/ARNHEM, NL

8339 Ceased/non-payment of the annual fee